Results of a randomised trial assessing the effectiveness of different dosages of levofloxacin to cure Helicobacter pylori infection

This dataset presents the results of a randomised clinical trial involving 400 participants, which aimed to compare the effectiveness, safety, and compliance of different dosages of levofloxacin used to cure Helicobacter pylori (H. pylori) infection. Patients were assigned to either Group A or Group B, and received esomeprazole, amoxicillin, colloidal bismuth pectin and levofloxacin 500 mg once per day (group A); or levofloxacin 200 mg twice per day (group B) over a 14 day period. The presence of H. pylori was assessed before and after the trial using c-urea breath testing (C-UBT). The dataset is comprised of an Excel spreadsheet with a single tab. Each of the 400 patients is assigned a number, and the dataset includes their baseline C-UBT result, randomised treatment group and follow-up C-UBT; any adverse reactions noted by patients during the trial period; and whether the study was completed per the protocol analysis.